Mar. Drugs 2009, 7(4), 754-786; doi:10.3390/md7040754
Review

Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition

email, email and * email
Received: 30 October 2009; in revised form: 18 November 2009 / Accepted: 27 November 2009 / Published: 1 December 2009
(This article belongs to the Special Issue Alkaloid Analogs)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial metabolites which have been described to inhibit topoisomerase I and diverse kinases, respectively. This review reports precisely on the synthesis and kinase inhibitory activities of pyrrolocarbazole-based analogues of granulatimide.
Keywords: granulatimide; isogranulatimide; pyrrolocarbazole; indolocarbazole; kinase inhibitor
PDF Full-text Download PDF Full-Text [955 KB, uploaded 1 December 2009 09:49 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Deslandes, S.; Chassaing, S.; Delfourne, E. Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition. Mar. Drugs 2009, 7, 754-786.

AMA Style

Deslandes S, Chassaing S, Delfourne E. Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition. Marine Drugs. 2009; 7(4):754-786.

Chicago/Turabian Style

Deslandes, Sébastien; Chassaing, Stefan; Delfourne, Evelyne. 2009. "Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition." Mar. Drugs 7, no. 4: 754-786.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert